RxDoctor Payments DataLook up a doctor →

Aaron Ambrad, MD

Radiation Oncology · Scottsdale, AZNPI 1265411961

Payments from drug & device makers

$30,289in general payments, 2019–2025

Across 738 payments — averaging $41.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$13K
  • AstraZeneca$3K
  • Novartis$1K
  • Johnson & Johnson$1K
  • Merck$943
  • Pfizer$644
  • plus $10K from 54 others

What the payments were for

  • Consulting fees$1,89010%
  • Food & beverage$16,14089%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novocure Inc.8$12,954
AstraZeneca(2 entities)50$2,954
Novartis84$1,365
Johnson & Johnson(2 entities)59$1,022
Merck43$943
Pfizer34$644
Sanofi29$633
Bayer17$565
Amgen27$560
Genentech USA, Inc.19$437
Eisai Inc.20$403
E.r. Squibb & Sons, L.L.C.22$381
Seagen Inc.20$371
Incyte Corporation17$339
AbbVie15$307
Astellas Pharma US Inc15$302
Lilly USA, LLC12$301
Bristol Myers Squibb15$293
Daiichi Sankyo Inc.13$292
Tersera Therapeutics LLC9$271
Pharmacyclics LLC, An Abbvie Company13$267
EMD Serono, Inc.15$260
Takeda Pharmaceuticals U.S.A., Inc.13$249
Exelixis Inc.9$213
Blueprint Medicines Corporation10$210
Endomagnetics Ltd2$196
Stemline Therapeutics Inc.3$189
Gilead8$178
Caris MPI, Inc.2$164
AVEO Pharmaceuticals, Inc.8$157
GSK9$157
Visionrt, Inc.2$155
Kyowa Kirin, Inc.8$148
Genmab U.S., Inc.5$145
Ipsen Biopharmaceuticals, Inc8$137
Elekta, Inc.2$125
Progenics Pharmaceuticals, Inc.5$111
Regeneron Healthcare Solutions, Inc.5$110
Boehringer Ingelheim6$110
Jazz Pharmaceuticals Inc.4$108
Karyopharm Therapeutics Inc.5$95
Lexicon Pharmaceuticals, Inc.2$89
Janssen Scientific Affairs, LLC2$84
Puma Biotechnology, Inc.4$83
Carbofix Orthopedics Inc1$80
Deciphera Pharmaceuticals Inc.3$79
Springworks Therapeutics, Inc.3$77
Sun Pharmaceutical Industries Inc.4$66
Geron Corporation2$58
Iovance Biotherapeutics, Inc.2$58
Morphosys, US Inc.3$53
Agios Pharmaceuticals, Inc.3$50
Clovis Oncology, Inc.3$49
Adaptive Biotechnologies Corporation2$44
Myovant Sciences Inc.3$40
Pharmaessentia USA Corporation2$38
Tesaro, Inc.3$37
Mylan Institutional Inc.2$33
Catalyst Pharmaceuticals, Inc.2$29
Rigel Pharmaceuticals, Inc.1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,289 in reported general payments places this provider in the 90th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024
$1,346,050
Medicare patients
354
Services billed
5,773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Scottsdale

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →